The researchers used conditional mice models for ADPKD to conduct long-term (10 or 50 weeks) dosing tests showing that HSP90 inhibition produced long-term in vivo cilia loss, regulated cystic development, and alleviated symptoms caused by Pkd1 or Pkd2 loss. Here, PKD1 is linked to autosomal dominant polycystic kidney disease.